Media October 10, 2022: Interview of Hervé Affagard in La Bourse et la Vie La Bourse et la Vie interviewed Hervé Affagard, CEO and co-founder of MaaT Pharma, during…MaaT PharmaOctober 13, 2022
Media July 2022: MaaT Pharma featured in MedNous Interview of Hervé Affagard published in the July-August 2022 edition of MedNous, a business-science publication…MaaT PharmaJuly 22, 2022
Media June 27, 2022: The microbiome revolution – presentation of Dr. Joël Doré Dive into the micobiome revolution with Dr. Joël Doré, INRAE Research Director, Scientific Director of…MaaT PharmaJune 27, 2022
Media June 13, 2022: MaaT Pharma in the top 3 biotechs to watch – Le Revenu (Article in French) MaaT PharmaJune 13, 2022
Media April 11, 2022: Interview of Hervé Affagard in Journal des biotechs – Boursorama MaaT PharmaApril 11, 2022
Media April 8, 2022: Article in French – MaaT Pharma launches its Phase 2a clinical trial in melanoma MaaT PharmaApril 8, 2022
Media March 30, 2022: Article in French – Microbiome: MaaT Pharma starts its phase III MaaT PharmaMarch 30, 2022